Dergiler / Eurasian Journal of Medicine / 2020 / Cilt: 52 - Sayı: 1

What Else Can We Use in The Discrimination of Activated MS Plaques in Addition to Diffusion MRI?

Sayfa
98–99
Yayın Tarihi
2022-10-18
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

One of these is theendothelin receptor antagonist bosentan.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Acute respiratory distress syndrome is characterized by dyspnea at presentation, tachypnea on physicalexamination, findings of bilateral infiltration in chest radiography, refractory hypoxia, and high mortality.Although the main treatment approach is to address the underlying disease, there are also pharmacologicaland nonpharmacological options for supportive treatment.
📊
Temel Bulgular & Veri:There is currently no pharmacological agent withproven efficacy in this syndrome, and many drugs are being studied for this purpose.
💡
Sonuç & Katkı:One of these is theendothelin receptor antagonist bosentan.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Acute respiratory distress syndrome is characterized by dyspnea at presentation, tachypnea on physicalexamination, findings of bilateral infiltration in chest radiography, refractory hypoxia, and high mortality.Although the main treatment approach is to address the underlying disease, there are also pharmacologicaland nonpharmacological options for supportive treatment. There is currently no pharmacological agent withproven efficacy in this syndrome, and many drugs are being studied for this purpose. One of these is theendothelin receptor antagonist bosentan.

🔖

Bu Makaleye Atıf Yap

KARAMAN, A. (2022). What Else Can We Use in The Discrimination of Activated MS Plaques in Addition to Diffusion MRI?. Eurasian Journal of Medicine, Cilt: 52 - Sayı: 1, 98–99. https://ajindex.com/articles/508878

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Unal S, Peker E, Erdogan S, et al. Is It Possible to Discriminate Active MS Lesions with Diffusion Weighted Imaging? Eurasian J Med 2019; 51: 219-23. [CrossRef] 2. Telischak NA, Detre JA, Zaharchuk G. Arterial spin labeling MRI: clinical applications in the brain. J Magn Reson Imaging 2015; 41: 1165-80. [CrossRef] 3. Evangelou N, Konz D, Esiri MM, et al. Regional axonal loss in the corpus callosum correlates with cerebral white matter lesion volume and distribution in multiple sclerosis. Brain 2000: 123; 1845-49. [CrossRef] 4. Filippi M, Rocca MA, De Stefano N, et al. Magnetic resonance techniques in multiple sclerosis: the present and the future. Arch Neurol 2011; 68: 1514-20. [CrossRef] 5. Naismith RT, Xu J, Tutlam NT, et al. Increased diffusivity in acute multiple sclerosis lesions predicts risk of black hole. Neurology 2010; 74: 1694- 701. [CrossRef] 6. Alper F, Kantarci M, Altunkaynak E, et al. Quantitative magnetic resonance imaging of brainstem volumes, plaques, and surface area in the occipital regions of patients with multiple sclerosis. Acta Radiol 2006; 47: 413-8. [CrossRef]